Study title: An open, randomised, cross over, active control study with two periods each of 2 weeks duration to investigate the stýstemic effects of low daily doses of ICS in 12 asthmatic children.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases [C08] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: BUDESONIDE | |||||
ATC code: | |||||
Document link: | |||||
Document date: 2014-10-16 | |||||
Study number: 04-2190 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |